Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism: reply.
J Thromb Haemost. 2014 Oct 16;
Authors: van der Hulle T, Huisman MV, Klok FA
In a response to our recent meta-analysis of the efficacy and safety of new oral anticoagulants (NOACs) in patients with cancer-associated acute venous thromboembolism (VTE), Dr. Di Minno and colleagues have focussed on an important issue, that was already put forward in our discussion: are the patients with cancer included in the randomised controlled trials investigating the NOACs representative to those usually seen in clinical practice and previous dedicated clinical trials? [1,2]. This article is protected by copyright. All rights reserved.
PMID: 25322961 [PubMed - as supplied by publisher]